Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sleijfer

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Clinical & Experimental Metastasis|November 3, 2022
Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastasesY M Meyer, S M Wilting, J Kraan, et al.
Cancer Gene Therapy|January 19, 2008
Retroviral vectors for clinical immunogene therapy are stable for up to 9 yearsC H J Lamers, P van Elzakker, B A Luider, et al.
British Journal of Cancer|May 21, 2010
Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignanciesP Hamberg, N Steeghs, W J Loos, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2012
A new approach for rapid and reliable enumeration of circulating endothelial cells in patientsJ Kraan, M H Strijbos, A M Sieuwerts, et al.
Plos One|May 23, 2017
Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatmentsS De Groot, H M Blommestein, W K Redekop, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 17, 2017
Health-related quality of life and its determinants in patients with metastatic renal cell carcinomaS de Groot, W K Redekop, M M Versteegh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 1, 1997
Effects of hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan on pulmonary function assessmentsS Sleijfer, R J van Ginkel, T W van der Mark, et al.
British Journal of Cancer|July 19, 2012
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG studyS Sleijfer, T Gorlia, C Lamers, et al.
Amino Acids|April 20, 2006
Influence of pegylated interferon-alpha therapy on plasma levels of citrulline and arginine in melanoma patientsD Fekkes, M Bannink, W H J Kruit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072B Kasper, S Sleijfer, S Litière, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Clinical & Experimental Metastasis|November 3, 2022
Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastasesY M Meyer, S M Wilting, J Kraan, et al.
Cancer Gene Therapy|January 19, 2008
Retroviral vectors for clinical immunogene therapy are stable for up to 9 yearsC H J Lamers, P van Elzakker, B A Luider, et al.
British Journal of Cancer|May 21, 2010
Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignanciesP Hamberg, N Steeghs, W J Loos, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2012
A new approach for rapid and reliable enumeration of circulating endothelial cells in patientsJ Kraan, M H Strijbos, A M Sieuwerts, et al.
Plos One|May 23, 2017
Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatmentsS De Groot, H M Blommestein, W K Redekop, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 17, 2017
Health-related quality of life and its determinants in patients with metastatic renal cell carcinomaS de Groot, W K Redekop, M M Versteegh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 1, 1997
Effects of hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan on pulmonary function assessmentsS Sleijfer, R J van Ginkel, T W van der Mark, et al.
British Journal of Cancer|July 19, 2012
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG studyS Sleijfer, T Gorlia, C Lamers, et al.
Amino Acids|April 20, 2006
Influence of pegylated interferon-alpha therapy on plasma levels of citrulline and arginine in melanoma patientsD Fekkes, M Bannink, W H J Kruit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072B Kasper, S Sleijfer, S Litière, et al.
Pageof 10